SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Chemo Pharma Laboratories informs about declaration of non-applicability of disclosure

09 Oct 2023 Evaluate
Chemo Pharma Laboratories has informed that it enclosed declaration of Non-Applicability of Regulation 23(9) of SEBI (LODR) Regulation, 2015 for the half year ended September 30, 2023.

The above information is a part of company’s filings submitted to BSE.

Starsource Multitrad Share Price

116.50 -6.10 (-4.98%)
17-Apr-2026 13:34 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.50
Dr. Reddys Lab 1230.00
Cipla 1236.55
Zydus Lifesciences 945.85
Lupin 2307.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×